Aelis Farma Is A Clinical Stage Biotechnology Company Based In Bordeauxfrancewith Laboratory Facilities In Pessacfounded In 2013The Company Specializes In Developing Innovative Therapeutics For Central Nervous Systemcnsdisordersaelis Farma Has Advanced Two Clinical Drug Candidates And Established A Proprietary Research Platform That Focuses On Signaling Specific Mechanisms To Address Brain Related Conditions With Unmet Medical Needs The Company S Pipeline Includes Aef0117Targeting Substance Use Disordersparticularly Cannabis Dependenceand Aef0217Aimed At Cognitive Disorders Such As Down Syndrome Related Cognitive Impairmentaelis Farma Also Develops A New Class Of Drugscb1 Ssidesigned To Modulate The Cb1 Receptor Without The Side Effects Associated With Traditional Cannabinoid Therapieswith A Revenue Of A 12 36M In 2023All Generated From Pharmaceutical R&D Activitiesaelis Farma Is Committed To Advancing Its Research And Development Efforts Within France
United States
